Growth Metrics

Gilead Sciences (GILD) Non-Current Debt (2016 - 2026)

Gilead Sciences filings provide 16 years of Non-Current Debt readings, the most recent being $22.1 billion for Q4 2025.

  • On a quarterly basis, Non-Current Debt fell 11.11% to $22.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $22.1 billion, a 11.11% decrease, with the full-year FY2025 number at $22.1 billion, down 11.11% from a year prior.
  • Non-Current Debt hit $22.1 billion in Q4 2025 for Gilead Sciences, roughly flat from $22.1 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $27.9 billion in Q2 2021 to a low of $21.2 billion in Q2 2023.
  • Median Non-Current Debt over the past 5 years was $23.0 billion (2022), compared with a mean of $23.5 billion.
  • Biggest five-year swings in Non-Current Debt: skyrocketed 32.28% in 2021 and later fell 15.82% in 2023.
  • Gilead Sciences' Non-Current Debt stood at $25.2 billion in 2021, then dropped by 8.82% to $23.0 billion in 2022, then increased by 1.01% to $23.2 billion in 2023, then rose by 7.36% to $24.9 billion in 2024, then dropped by 11.11% to $22.1 billion in 2025.
  • The last three reported values for Non-Current Debt were $22.1 billion (Q4 2025), $22.1 billion (Q3 2025), and $22.1 billion (Q2 2025) per Business Quant data.